Grant: Engage Grants Program
University of Manitoba
$25,000.00
New anti-biofilm formulations and products
FY 2018-19
Summary
Biofilm formation on medical devices can cause persistent infections. The main feature of biofilms is their*self-produced extracellular polymeric substances (EPSs) that act as a protective shield to prevent biocide*penetration. Kane Biotech Inc. has been working on biofilm removal and dispersal. Kane Biotech has a*proprietary enzyme that can be used to break down and disperse biofilms. They are interested in developing*new products with higher potency in removing biofilms in both industrial and healthcare sectors. My research*group has successfully used Iron oxide magnetic nanoparticles (MNPs), synthesized through a simple process,*as ""shield breakers"" to negatively impact the integrity of biofilm EPS and cause biofilm detachment. The*Methicillin-resistant Staphylococcus aureus (MRSA) strain was used to demonstrate the efficacy of MNPs. The*highest logarithmic reduction (4.71 log) of MRSA biofilm was achieved after the treatment with 30 mg/mL of*11 nm MNPs under rotating magnetic field for 15 minutes. MNPs caused strong mechanical disruption to the*matrix and led to biofilm dispersal. Both alternating and rotating magnetic fields improved the effect of MNPs*on biofilm damage. The increased MNPs solution temperature caused by the hyperthermic effect in the AC*field led to biofilm dispersal while the MNPs caused physical damage on biofilms in a rotating magnetic field.*We hypothesize that combination of the MNPs synthesized in our lab with Kane Biotech's proprietary*anti-biofilm enzyme will lead to new formulations and products with synergistic anti-biofilm activity. That can*be translated to new anti-biofilm products that Kane can commercialize.
Program
Engage Grants Program
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
532621-2018
Name nom
Liu, Song
Department département
Biosystems Engineering
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
1
Nb partie
1
Application title
New anti-biofilm formulations and products
Keyword
NSERC
Application summary
Biofilm formation on medical devices can cause persistent infections. The main feature of biofilms is their*self-produced extracellular polymeric substances (EPSs) that act as a protective shield to prevent biocide*penetration. Kane Biotech Inc. has been working on biofilm removal and dispersal. Kane Biotech has a*proprietary enzyme that can be used to break down and disperse biofilms. They are interested in developing*new products with higher potency in removing biofilms in both industrial and healthcare sectors. My research*group has successfully used Iron oxide magnetic nanoparticles (MNPs), synthesized through a simple process,*as ""shield breakers"" to negatively impact the integrity of biofilm EPS and cause biofilm detachment. The*Methicillin-resistant Staphylococcus aureus (MRSA) strain was used to demonstrate the efficacy of MNPs. The*highest logarithmic reduction (4.71 log) of MRSA biofilm was achieved after the treatment with 30 mg/mL of*11 nm MNPs under rotating magnetic field for 15 minutes. MNPs caused strong mechanical disruption to the*matrix and led to biofilm dispersal. Both alternating and rotating magnetic fields improved the effect of MNPs*on biofilm damage. The increased MNPs solution temperature caused by the hyperthermic effect in the AC*field led to biofilm dispersal while the MNPs caused physical damage on biofilms in a rotating magnetic field.*We hypothesize that combination of the MNPs synthesized in our lab with Kane Biotech's proprietary*anti-biofilm enzyme will lead to new formulations and products with synergistic anti-biofilm activity. That can*be translated to new anti-biofilm products that Kane can commercialize.